Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AB1211-100UL Anti-β Galactosidase Antibody

AB1211-100UL
100 µL  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
Vrt, E. coliELISA, IHC, IP, WBRbPurifiedPolyclonal Antibody
Description
Catalogue NumberAB1211-100UL
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-β Galactosidase Antibody
References
Product Information
FormatPurified
Control
  • Proteins tagged with beta galactosidase
PresentationImmunoglobulin Purified by delipidation, salt fractionation and ion-exchange chromatography. Liquid in 0.02M Potassium Phosphate buffer, 0.15M Sodium Chloride, with 0.01% sodium azide.
Quality LevelMQ100
Applications
ApplicationAnti-β Galactosidase Antibody is an antibody against β Galactosidase for use in ELISA, Immunohistochemistry, Immunoprecipitation, Western Blotting.
Key Applications
  • ELISA
  • Immunohistochemistry
  • Immunoprecipitation
  • Western Blotting
Application NotesELISA: 1:10,000-1:50,000 when assayed against 1 μg of Beta Galactosidase in a standard sandwich ELISA.

Immunoblotting: 1:2000-1:10,000 on beta-galactosidase fusion proteins.

Immunohistochemistry: 1:1,000-1:5000 on tissue fixed with 4% paraformaldehyde.

Immunoprecipitation

Optimal working dilutions must be determined by end user.
Biological Information
ImmunogenBeta-Galactosidase (E. coli).
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostRabbit
SpecificityRecognizes Beta-Galactosidase (E. coli). Monospecific by IEP. Some cross reactivity with Beta Galactosidase from other species may occur.
Species Reactivity
  • Vertebrates
  • E. coli
Antibody TypePolyclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThe GLB1 gene encodes beta-galactosidase-1 (EC 3.2.1.23), a lysosomal hydrolase that cleaves the terminal beta-galactose from ganglioside substrates and other glycoconjugates (Yoshida et al., 1991 [PubMed 1907800]). Beta-galactosidase also occurs in a complex with neuraminidase (NEU1; MIM 608272) and protective protein/cathepsin A (PPCA; MIM 256540), which is a component of certain cell surface receptors (Hinek, 1996 [PubMed 8922281]). See also galactosylceramidase (GALC; MIM 606890) (EC 3.2.1.46), a genetically distinct beta-galactosidase that is involved in the catabolism of other lipid compounds.[supplied by OMIM]
Gene Symbol
  • GLB1
  • Lactase
  • S-Gal
  • ELNR1
  • EBP
Purification MethodAmmonium sulfate precipitation and DEAE-cellulose chromatography
UniProt Number
UniProt SummaryFUNCTION: SwissProt: P16279 # This protein has no beta-galactosidase catalytic activity, but plays functional roles in the formation of extracellular elastic fibers (elastogenesis) and in the development of connective tissue. Seems to be identical to the elastin-binding protein (EBP), a major component of the non- integrin cell surface receptor expressed on fibroblasts, smooth muscle cells, chondroblasts, leukocytes, and certain cancer cell types. In elastin producing cells, associates with tropoelastin intracellularly and functions as a recycling molecular chaperone which facilitates the secretions of tropoelastin and its assembly into elastic fibers.| P16278 # Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans.
SIZE: 546 amino acids; 60552 Da
SUBCELLULAR LOCATION: Cytoplasm, perinuclear region. Note=Localized to the perinuclear area of the cytoplasm but not to lysosomes.
DOMAIN: SwissProt: P16279
DISEASE: SwissProt: P16278 # Defects in GLB1 are the cause of GM1-gangliosidosis type I [MIM:230500]; also known as infantile GM1-gangliosidosis. This autosomal recessive disorder is characterized by the accumulation in visceral tissues, and ultimately excessive excretion in the urine, of beta-linked galactose-terminal oligosaccharides. Patients show central nervous system degeneration, and the coarse facial features, hepatosplenomegaly and skeletal dysmorphology reminiscent of Hurler syndrome. The infantile form is rapidly progressive leading to death usually between the first and second year. & Defects in GLB1 are the cause of GM1-gangliosidosis type II [MIM:230600]; also known as late infantile/juvenile type GM1- gangliosidosis. Patients do not display the skeletal changes associated with the infantile form, but they nonetheless excrete elevated amounts of beta-linked galactose-terminal oligosaccharides. Inheritance is autosomal recessive. & Defects in GLB1 are the cause of GM1-gangliosidosis type III [MIM:230650]; also known as adult or chronic GM1- gangliosidosis. Patients show mild skeletal abnormalities, dysarthria, gait disturbance, dystonia and visual impairment. Visceromegaly is absent. Inheritance is autosomal recessive. & Defects in GLB1 are the cause of mucopolysaccharidosis IV B (MPS4B) [MIM:253010]; also known as Morquio syndrome B. MPS4B is a rare autosomal recessive disorder characterized by severe bone deformities without CNS involvement.
SIMILARITY: SwissProt: P16279 ## Belongs to the glycosyl hydrolase 35 family. | P16278 ## Belongs to the glycosyl hydrolase 35 family.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain for 2 years at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Packaging Information
Material Size100 µL
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
AB1211-100UL 04055977161939

Documentation

Anti-β Galactosidase Antibody SDS

Title

Safety Data Sheet (SDS) 

Anti-β Galactosidase Antibody Certificates of Analysis

TitleLot Number
RABBIT ANTI-BETA-GALACTOSIDASE (E. coli) - 3773104 3773104
RABBIT ANTI-BETA-GALACTOSIDASE (E. coli) - 3934289 3934289
RABBIT ANTI-BETA-GALACTOSIDASE (E. coli) - 4045178 4045178
RABBIT ANTI-BETA-GALACTOSIDASE (E. coli) POLYCLONAL ANTIBODY 3083530
RABBIT ANTI-BETA-GALACTOSIDASE (E. coli) POLYCLONAL ANTIBODY 2950526
RABBIT ANTI-BETA-GALACTOSIDASE - 3574346 3574346
RABBIT ANTI-BETA-GALACTOSIDASE - 3991437 3991437
RABBIT ANTI-BETA-GALACTOSIDASE -2565753 2565753
RABBIT ANTI-BETA-GALACTOSIDASE -Q2537389 Q2537389

References

Reference overviewPub Med ID
Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve.
Perlson, Eran, et al.
Neuron, 45: 715-26 (2005)  2005

Show Abstract
15748847 15748847